ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption

Circulation

Volumn 95, Issue 1, 1997, Pages 176-182

  Zhang, Xiaoping ^b   Xie, Yi Wu ^b   Nasjletti, Alberto ^a   Xu, Xiaobin ^b   Wolin, Michael S ^b   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

endothelium derived factors; enzymes; oxygen

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; KININ; NITRIC OXIDE; RAMIPRILAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY DILATATION; DOG; DRUG EFFECT; HEART MUSCLE OXYGEN CONSUMPTION; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL;

EID: 0031014498     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.1.176     Document Type: Article

References (11)

1. Mombouli JV, Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol, 1995;35: 679-705.
2. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
3. Hecker M, Bara AT, Busse B. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium. Eur Heart J. 1993;14(suppl I):161-163.
4. Linz W, Wiemer G, Scholhens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol. 1993;22(suppl 9):S1-S8.
5. Vanhoutte PM, Schwelk WA, Biondi ML, Lorenz RR, Schini VB, Vidal MJ. Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol. 1989;28:95S-104S.
6. Mombouli JV, Iillaino S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992;71:137-144.
7. Hecker M, Bara AT, Busse R. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins. J Vase Res. 1993:30:257-262.
8. Schwelk WA, Kuchenbuch C, Claus M, Walther B, Bossaller C, Friedel N, Graf K, Grafe M, Fleck E. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors. Eur Heart J. 1993;14(suppl I):154-160.
9. Desta B, Nakashima M, Circhengast M, Vanhoutte PM, Boulanger C. Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries. J Pharmacol Exp Ther. 1995; 272:885-891.
10. Mombouli JV, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s) and the potentiation of kinins by converting enzyme inhibitors. Am J Hypertens. 1995;8:19S-27S.
11. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987:327:524-526.